PT  - JOURNAL ARTICLE
AU  - Kai Wen Leong
AU  - Kasha P Singh
AU  - Karin Leder
AU  - Steven Y C Tong
TI  - Acute kidney injury secondary to severe delayed haemolysis in intravenous artesunate use for severe malaria
AID  - 10.1136/bcr-2020-237501
DP  - 2021 Jan 01
TA  - BMJ Case Reports
PG  - e237501
VI  - 14
IP  - 1
4099  - http://casereports.bmj.com/content/14/1/e237501.short
4100  - http://casereports.bmj.com/content/14/1/e237501.full
SO  - BMJ Case Reports2021 Jan 01; 14
AB  - The use of artemisinin derivatives has been recommended by the WHO guidelines in malaria treatment largely due to its rapid parasite clearance and safety profile. This case report details the development of delayed haemolysis and subsequent severe acute kidney injury (AKI) 13 days after commencing intravenous artesunate treatment for malaria in an Australian returned traveller. Delayed haemolysis may be an under-recognised complication following artesunate use and if severe, can be complicated by AKI. Therefore, close patient follow-up following treatment is required to ensure prompt recognition of this phenomenon.